Target intelligence / Profile preview

UspA2 protein (UspA2)

Target
UspA2
Molecular classification
Bacterial outer membrane protein, Autotransporter protein, Adhesin, Other
01

Overview

UspA2 protein is a large, coiled-coil, trimeric autotransporter adhesin (~62 kDa monomer, forms high-molecular-weight oligomers)[4] presented on the surface of nearly all clinical isolates of *M. catarrhalis*[1][4][5]. UspA2 confers resistance to complement-mediated killing by binding human serum proteins such as vitronectin, C4b-binding protein, factor H, and plasminogen, thereby preventing membrane attack complex (MAC) formation and promoting survival in the human host[1][5]. It also contributes to bacterial adhesion to host cells via host receptor and ECM protein (vitronectin and integrins) binding[3]. UspA2 is immunogenic and a target for vaccine development; its exposed domains are recognized by biologically active antibodies[1][2][3][4][5]. Genetic exchange and recombination within the UspA family (including UspA1, UspA2, and hybrid forms) drive antigenic diversity and may influence functional properties related to adhesion and immune evasion[2][3].

Other names
UspA2 adhesinUspA2 surface proteinUniversal stress protein A2
02

Mechanism of action

Experimental drugs/fusion proteins block complement evasion by binding UspA2 to enhance complement-mediated bacterial killing

03

Biological functions

Immune evasion (serum/complement resistance)Adhesion to human cellsBinding to host proteins (vitronectin, C4b-binding protein, factor H, plasminogen)
04

Disease associations

Infection (acute otitis media, exacerbation of COPD, respiratory tract infections)Pathogenesis in human mucosal surfaces
05

Safety considerations

Potential for antigenic variation due to genetic recombination in UspA family may limit the breadth of protection or facilitate immune evasion in vaccinesNo traditional drug-targeted safety concerns described; as a bacterial protein, relevant to immune responses/vaccine safety
06

Interacting drugs

Experimental fusion proteins such as FH6–7/IgG and C4BP1–2/IgM (investigational, not clinical drugs)
07

Biomarkers

UspA2 is a candidate biomarker for *M. catarrhalis* infection and immune response (used in assays and vaccine studies)

Beyond the preview

Go deeper on UspA2 protein (UspA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UspA2 protein (UspA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call